About us
Products
Distribution
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Home » News » Celadrin per Deejay Ten

Celadrin per Deejay Ten

Published: 27 May 2013 11:17

La Deejay TEN si è conclusa con un grande successo!

Eravamo tantissimi…

<< Articolo precedente Next Article >>

Related News

The sucrosomial iron technology in Zurich...

"The European Iron Club 2018", the most important European meeting focused on scientific research and...
World Partners Convention 2018: a borderless...

This week PharmaNutra S.p.A. was engaged in the first edition of the World Partners Convention 2018,...

Related Products

UltraMag

UltraMag^® is a food supplement with magnesium, that is useful to cover dietary deficiencies...
Novomega

Nutritional supplement containing EPA and DHA aimed at treating alimentary deficiency or as a complement...

Pharmanutra PLC is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

AWARDS

Ai sensi delle Nuove Linee guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro, presidi medico chirurgici e medicinali da banco, si avvisa l'utente che le informazioni ivi contenute sono esclusivamente rivolte agli operatori professionali.

© Copyright - PHARMANUTRA.IT. All Rights Reserved.

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More